Verition Fund Management’s Lucid Diagnostics LUCD Stock Holding History

Verition Fund Management’s Portfolio LUCD Stock Details LUCD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-39,711	Closed	-$32.4K	–	3391
2024 Q3	$32.4K	Hold	39,711	–	–	﹤0.01%	3058
2024 Q2	$32.6K	Sell	39,711 -2,668	-6%	-$2.26K	﹤0.01%	2832
2024 Q1	$34.3K	Buy	42,379 +6,213	+17%	+$8.06K	﹤0.01%	2655
2023 Q4	$51K	Hold	36,166	–	–	﹤0.01%	2177
2023 Q3	$42.3K	Hold	36,166	–	–	﹤0.01%	2195
2023 Q2	$50.3K	Sell	36,166 -14,296	-28%	-$21.5K	﹤0.01%	2040
2023 Q1	$70.6K	Buy	50,462 +14,296	+40%	+$19.8K	﹤0.01%	1937
2022 Q4	$49.2K	Hold	36,166	–	–	﹤0.01%	1889
2022 Q3	$55K	Sell	36,166 -10,543	-23%	-$26.2K	﹤0.01%	2686
2022 Q2	$106K	Buy	46,709 +10,543	+29%	+$23.4K	﹤0.01%	2066
2022 Q1	$122K	Buy	+36,166	New	+$132K	﹤0.01%	2413

Other funds holding LUCD

Luminus Management Houston, Texas $166M AUM 75.95% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SIG

Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Lido Advisors Los Angeles, California $32.7B AUM 19.2% 1-Year Est. Return

GAM

Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Sunbelt Securities Houston, Texas $1.58B AUM 28.96% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Verition Fund Management's LUCD Position: Q4 2024 in Review

Verition Fund Management sold out of Lucid Diagnostics (LUCD) in Q4 2024, closing a stake of 39,711 shares — an estimated $32.4K sold.

Verition Fund Management first reported a position in LUCD in Q1 2022 and held it in 11 quarters. The position peaked at $122K in Q1 2022. 33 funds tracked by Wall St. Rank hold LUCD as of Q4 2024.

Verition Fund Management reported no remaining Lucid Diagnostics position as of Q4 2024 after selling out during the quarter.
Verition Fund Management sold 39,711 Lucid Diagnostics shares in Q4 2024, an estimated $32.4K.
Verition Fund Management first reported a position in Lucid Diagnostics in Q1 2022 and held it in 11 quarters.
Verition Fund Management's Lucid Diagnostics position peaked at $122K in Q1 2022.
33 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q4 2024.

Based on Verition Fund Management's 13F filing for Q4 2024, filed 14 Feb 2025.